FDA warns Steris Isomedix on QA, data manipulation issues

FDA warns Steris Isomedix on QA issues

Steris’s (NYSE:STE) Isomedix division is in the FDA’s hotseat after inspectors turned up incidents in which employees faked data on testing for medical devices.

The FDA this week unveiled a warning letter in which investigators chided Steris for failing to protect against data manipulation and for subsequently mishandling the incidents.

Steris spokesman Stephen Norton told MassDevice.com today that the company was taking steps to address all of the FDA’s concerns and that Steris doesn’t expect the inspection to have a material impact on the company’s financial results.

"Steris takes regulatory issues very seriously and are working diligently to remediate the concerns of the FDA," Norton told us. "The FDA notes nine items in the warning letter, which stemmed from a January, 2014 inspection of our Libertyville Isomedix facility. The concerns raised by the FDA are related to the processes and procedures at the facility. Since the inspection, Steris has provided detailed responses to the FDA regarding corrective actions taken, and is implementing a number of improvements to our systems."

The FDA investigation turned up 3 incidents since 2008 in which 5 employees at 3 different Isomedix facilities manipulated data regarding dosimetric testing. The FDA further cited instances of missing records, including some that were intentionally deleted. Steris’ response to the FDA’s concerns were deemed insufficient, the FDA said.

"We have reviewed your responses and have determined that they are inadequate because the responses failed to identify actions to address the reasons why it took 3 discrete incidents of data manipulation/falsification and an FDA inspection to initiate a change in the quality system," according to the warning letter.

Some 2,900 records were also reportedly missing from the Dosimetry Measurement Application module, most of which was chalked up to deliberate deletion while others were deemed the result of a computer error.

Isomedix informed the FDA that it had made process changes, including implementing a new policy on re-reading dosimeters, but inspectors said that the company failed to provide proof or documentation of the changes.

The FDA also chided Isomedix for failing to properly warn customers who received products with potentially manipulated dosimetric data.

"On July 29, 2013 your firm’s Libertyville North facility initiated an investigation … into product runs that were overdosed and were subsequently made to appear within customer specification by employee data falsification and manipulation of dosimetric equipment," the FDA said. "This investigation identified approximately 89 runs as potentially affected. Your firm did not inform all of the identified customers that the dosimetric testing of their products may have been subject to falsification of dosimetric data."

Isomedix apparently made moves to inform customers of the situation, but the FDA maintained that the company hadn’t provided documentation proving that it had taken the appropriate steps.

Inspectors plan to conduct a follow-up investigation to check on some of the company’s new quality controls, the agency said.

 

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply